CARM1 and ovarian carcinoma: In summary, while NAC1 is currently considered to act as a transcription suppressor based on previous studies focusing on neuronal cells, the present study showed that NAC1 may act as a transcriptional activator to fulfill the oncogenic potential in ovarian cancer cells in cooperation with the interacting partner CARM1.